Medical Devices Startups

German health care data services provider supplying market and health care research analytics, acquired by CompuGroup Medical.

1 investor

Inspirata provides a natural language processing engine that analyzes medical records, clinical notes, and genomics reports to automate cancer data extraction and clinical research workflows. The platform serves oncology departments, cancer registries, and healthcare organizations seeking to accelerate cancer research and improve clinical decision-making.

1 investor

hominin builds AI models that analyze human movement patterns from wearable data to generate personalized health and recovery insights for surgical recovery, athletic training, and longevity applications. The company converts movement data into biomarkers for musculoskeletal and neurological health monitoring.

1 investor

Instituto Bernabeu's Genetic and Reproductive Counseling Unit provides personalized reproductive advice using a multidisciplinary approach for couples and individuals in reproductive age. The service includes genetic risk assessment, family history evaluation, and diagnostic planning for families with genetic conditions or adverse pregnancy outcomes.

1 investor

InTech Medical (operating as EXALTA) provides turnkey OEM manufacturing and engineering solutions for medical devices, primarily serving orthopedic and surgical device companies from concept through regulatory clearance and production launch. The company offers integrated design, regulatory, and manufacturing services with a global footprint.

1 investor

Integrated Diagnostic Services operates a network of mobile diagnostic providers delivering diagnostic care at patients' locations. The company partners with local diagnostic providers, supporting them with capital, operational expertise, and infrastructure to scale their services.

1 investor

Intelerad, now a GE HealthCare company, builds cloud-based medical imaging software that captures, stores, and shares diagnostic images and connects physicians and clinical staff across departments. Its portfolio serves healthcare systems and clinicians with workflow orchestration, image sharing, and advanced cardio viewing tools.

1 investor

This page is an informational article comparing CME (Continuing Medical Education) learning platforms. It is not a company website.

1 investor

Interactive Metronome is a therapeutic intervention developed to improve attention, motor control, language processing, and impulse control in children with learning and developmental disorders and adults recovering from neurological conditions. The technology is delivered by certified providers in over 60 countries and has supported more than 1 million clients.

1 investor

Interleukin operates a B2B platform for sourcing and procuring medical products and services, letting registered buyers discover accredited suppliers, request quotes, send purchase orders, and pay on terms in one system. It targets medical institution buyers and distributors/suppliers in the Philippines.

1 investor

Interna develops a molecular delivery platform that transports large molecule therapeutics such as DNA, RNA, and proteins across cell membranes to treat infectious and non-infectious diseases. The company's molecular nano-motor technology harnesses the cell membrane's electric potential to enable intracellular drug delivery for respiratory and other therapeutic applications.

1 investor

Interpace Biosciences provides molecular diagnostic tests for the early diagnosis and treatment of cancer, with a focus on risk-stratifying indeterminate thyroid nodules through genetic and mutational analysis. The company serves specialty physicians and medical centers in the U.S. and internationally.

1 investor

Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms. It targets select heart failure patients with reduced ejection fraction and is being evaluated in the EASE HF2 early feasibility clinical study.

1 investor

Intervacc develops veterinary vaccines based on recombinant protein fusions. The company's lead product, Strangvac®, prevents strangles in horses, a serious and contagious global disease, and is available on several major European markets.

1 investor

Intragel is developing SRGel, a solvent-free long-acting injectable (LAI) drug delivery platform designed to enable controlled, extended release from a single injection for small molecules, peptides and biologics. The platform aims to extend dosing intervals and reduce injection frequency across multiple therapeutic areas.

1 investor

Intracare Health Services is a licensed, insured, and nationally accredited health services provider. This page is a careers/recruitment page inviting professionals to apply to join the team.

1 investor

A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.

1 investor

IntraOp develops the Mobetron, a compact and mobile linear accelerator for electron therapy used to treat cancer, including intraoperative radiotherapy (IORT), non-invasive skin cancer treatment, and ultra-high dose rate (UHDR) FLASH research. Its systems are used by oncologists, hospitals, and research centers to deliver radiation therapy at the point of care.

1 investor

Intressa Vascular develops the Allay Aortic Stent using proprietary multilayer braiding technology and personalized procedure planning to treat aortic dissections in patients requiring endovascular intervention.

1 investor

Intron Biotechnology is a South Korean biotech company developing novel drugs based on bacteriophage platform technology, including "First-in-Class" treatments for multidrug-resistant superbacteria and "First-in-Concept" therapeutics targeting microbiome, viruses, and immune modulation. It positions itself as a global R&BD group in the biopharmaceutical field.

1 investor

IntuiTap Medical makes VerTouch+, an FDA-cleared handheld imaging device that generates a real-time 2D map (TactoMap) of lumbar anatomy to guide bedside needle placement for neuraxial procedures such as spinal punctures. It is used by clinicians including physicians, PAs, and CRNAs to improve accuracy and consistency of spinal procedures while reducing reliance on radiology.

1 investor

Intuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.

1 investor

InvenireX advances molecular diagnostics in life sciences through innovation in biotechnology. The company develops solutions for scientific research and healthcare applications.

1 investor

Inventia Life Science develops 3D cell culture platforms and standardized cell models for drug discovery, cancer research, and toxicity screening. The platform enables reproducible, human-relevant assays for pharmaceutical and biotech research teams.

1 investor